Pluri, Inc. (PLUR)
0.9532
-0.05
(-4.68%)
USD |
NASDAQ |
Oct 09, 16:00
1.00
+0.05
(+4.91%)
Pre-Market: 20:00
Pluri Net Income (Quarterly) : -6.193M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.193M |
| March 31, 2026 | -6.172M |
| December 31, 2025 | -6.872M |
| September 30, 2025 | -6.132M |
| June 30, 2025 | -7.769M |
| March 31, 2025 | -6.335M |
| December 31, 2024 | -3.11M |
| September 30, 2024 | -6.036M |
| June 30, 2024 | -5.862M |
| March 31, 2024 | -5.39M |
| December 31, 2023 | -4.994M |
| September 30, 2023 | -5.098M |
| June 30, 2023 | -6.606M |
| March 31, 2023 | -7.758M |
| December 31, 2022 | -8.254M |
| September 30, 2022 | -6.269M |
| June 30, 2022 | -9.084M |
| March 31, 2022 | -9.918M |
| December 31, 2021 | -10.94M |
| September 30, 2021 | -11.43M |
| June 30, 2021 | -14.57M |
| March 31, 2021 | -14.25M |
| December 31, 2020 | -12.55M |
| September 30, 2020 | -8.489M |
| June 30, 2020 | -8.136M |
| Date | Value |
|---|---|
| March 31, 2020 | -7.507M |
| December 31, 2019 | -6.37M |
| September 30, 2019 | -7.139M |
| June 30, 2019 | -7.76M |
| March 31, 2019 | -10.08M |
| December 31, 2018 | -8.683M |
| September 30, 2018 | -8.786M |
| June 30, 2018 | -8.981M |
| March 31, 2018 | -1.531M |
| December 31, 2017 | -8.229M |
| September 30, 2017 | -7.385M |
| June 30, 2017 | -7.016M |
| March 31, 2017 | -7.864M |
| December 31, 2016 | -6.61M |
| September 30, 2016 | -6.324M |
| June 30, 2016 | -6.205M |
| March 31, 2016 | -7.203M |
| December 31, 2015 | -3.962M |
| September 30, 2015 | -5.876M |
| June 30, 2015 | -5.295M |
| March 31, 2015 | -7.226M |
| December 31, 2014 | -6.245M |
| September 30, 2014 | -5.911M |
| June 30, 2014 | -6.196M |
| March 31, 2014 | -9.276M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Compugen Ltd. | -7.006M |
| Evogene Ltd. | -1.591M |
| Scinai Immunotherapeutics Ltd. | -2.037M |
| CollPlant Biotechnologies Ltd. | -2.726M |
| Regentis Biomaterials Ltd. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.335M |
| Total Expenses (Quarterly) | 6.215M |
| EPS Diluted (Quarterly) | -0.5432 |
| Enterprise Value | 43.00M |
| Gross Profit Margin (Quarterly) | 21.49% |
| Profit Margin (Quarterly) | -1.85K% |
| Earnings Yield | -257.2% |
| Normalized Earnings Yield | -259.49 |